The role of PET in the evaluation of musculoskeletal infections

Seminars in Musculoskeletal Radiology

Volumn 18, Issue 2, 2014, Pages 166-174

  Rowe, Steven P ^a   Cho, Steve Y ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

fluorodeoxyglucose (FDG); musculoskeletal infection; positron emission tomography (PET)

Indexed keywords

C REACTIVE PROTEIN; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; GALLIUM CITRATE GA 67; MEDRONATE TECHNETIUM TC 99M; TRACER; 2-FLUORO-2-DEOXYGLUCOSE-6-PHOSPHATE; GLUCOSE 6 PHOSPHATE;

ARTICLE; BONE INFECTION; BONE SCINTISCANNING; CHRONIC OSTEOMYELITIS; CLINICAL EVALUATION; DIABETIC FOOT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISKITIS; ERYTHROCYTE SEDIMENTATION RATE; HIP ARTHROPLASTY; HUMAN; INFECTION; JOINT PROSTHESIS; KNEE ARTHROPLASTY; META ANALYSIS (TOPIC); MOLECULAR IMAGING; MUSCULOSKELETAL DISEASE; MUSCULOSKELETAL INFECTION; NEUROPATHIC JOINT DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPROSTHETIC INFECTION; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTHESIS INFECTION; PROSTHESIS LOOSENING; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPINE DISEASE; SPINE INFECTION; SYSTEMATIC REVIEW (TOPIC); TREATMENT PLANNING; ANALOGS AND DERIVATIVES; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; MUSCULOSKELETAL DISEASES; PROSTHESIS-RELATED INFECTIONS; SCINTISCANNING; SPINAL DISEASES;

DIABETIC FOOT; GLUCOSE-6-PHOSPHATE; HUMANS; INFECTION; MUSCULOSKELETAL DISEASES; POSITRON-EMISSION TOMOGRAPHY; PROSTHESIS-RELATED INFECTIONS; SPINAL DISEASES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84898455995     PISSN: 10897860     EISSN: 1098898X     Source Type: Journal    
DOI: 10.1055/s-0034-1371018     Document Type: Article

References (64)

1. Love C., Tomas M. B., Tronco G. G., Palestro C. J. FDG PET of infection and inflammation. Radiographics: 2005; 25 5 1357 1368 (Pubitemid 41695350)
2. Mariani G., Bruselli L., Kuwert T., et al. A review on the clinical uses of SPECT/CT. Eur J Nucl Med Mol Imaging: 2010; 37 10 1959 1985
3. Scharf S. SPECT/CT imaging in general orthopedic practice. Semin Nucl Med: 2009; 39 5 293 307
4. Cheng G., Fosse P., Zhuang H., Hustinx R. Applications of PET and PET/CT in the evaluation of infection and inflammation in the skeletal system. PET Clin: 2010; 5 3 375 385
5. de Winter F., van de Wiele C., Vogelaers D., de Smet K., Verdonk R., Dierckx R. A. Fluorine-18 fluorodeoxyglucose-position emission tomography: a highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections. J Bone Joint Surg Am: 2001; 83-A 5 651 660
6. Kälicke T., Schmitz A., Risse J. H., et al. Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: results of histologically confirmed cases. Eur J Nucl Med: 2000; 27 5 524 528 (Pubitemid 30262617)
7. Palestro C. J., Love C., Miller T. T. Infection and musculoskeletal conditions: imaging of musculoskeletal infections. Best Pract Res Clin Rheumatol: 2006; 20 6 1197 1218
8. Palestro C. J. FDG-PET in musculoskeletal infections. Semin Nucl Med: 2013; 43 5 367 376
9. Zhuang H., Yu J. Q., Alavi A. Applications of fluorodeoxyglucose-PET imaging in the detection of infection and inflammation and other benign disorders. Radiol Clin North Am: 2005; 43 1 121 134 (Pubitemid 40326564)
10. Goldsmith S. J., Vallabhajosula S. Clinically proven radiopharmaceuticals for infection imaging: mechanisms and applications. Semin Nucl Med: 2009; 39 1 2 10
11. Basu S., Chryssikos T., Moghadam-Kia S., Zhuang H., Torigian D. A., Alavi A. Positron emission tomography as a diagnostic tool in infection: present role and future possibilities. Semin Nucl Med: 2009; 39 1 36 51
12. Hartmann A., Eid K., Dora C., Trentz O., von Schulthess G. K., Stumpe K. D. Diagnostic value of 18F-FDG PET/CT in trauma patients with suspected chronic osteomyelitis. Eur J Nucl Med Mol Imaging: 2007; 34 5 704 714 (Pubitemid 46669361)
13. Kim S. J., Lee J. S., Suh K. T., Kim I. J., Kim Y. K. Differentiation of tuberculous and pyogenic spondylitis using double phase F-18 FDG PET. Open Med Imaging J: 2008; 2 1 6
14. Sathekge M., Maes A., Van de Wiele C. FDG-PET imaging in HIV infection and tuberculosis. Semin Nucl Med: 2013; 43 5 349 366
15. Zhuang H., Duarte P. S., Pourdehand M., Shnier D., Alavi A. Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging. Clin Nucl Med: 2000; 25 4 281 284 (Pubitemid 30173879)
16. Mochizuki T., Tsukamoto E., Kuge Y., et al. FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models. J Nucl Med: 2001; 42 10 1551 1555 (Pubitemid 32953137)
17. Paik J. Y., Lee K. H., Choe Y. S., Choi Y., Kim B. T. Augmented 18F-FDG uptake in activated monocytes occurs during the priming process and involves tyrosine kinases and protein kinase C. J Nucl Med: 2004; 45 1 124 128 (Pubitemid 47611618)
18. Sarrazin J-F, Philippon F., Tessier M., et al. Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. J Am Coll Cardiol: 2012; 59 18 1616 1625
19. Kouijzer I. J., Bleeker-Rovers C. P., Oyen W. J. FDG-PET in fever of unknown origin. Semin Nucl Med: 2013; 43 5 333 339
20. Gemmel F., Dumarey N., Palestro C. J. Radionuclide imaging of spinal infections. Eur J Nucl Med Mol Imaging: 2006; 33 10 1226 1237 (Pubitemid 44484480)
21. Palestro C. J., Love C. Radionuclide imaging of musculoskeletal infection: conventional agents. Semin Musculoskelet Radiol: 2007; 11 4 335 352 (Pubitemid 351415487)
22. Treglia G., Focacci C., Caldarella C., et al. The role of nuclear medicine in the diagnosis of spondylodiscitis. Eur Rev Med Pharmacol Sci: 2012; 16 02 20 25
23. Gemmel F., Rijk P. C., Collins J. MP, Parlevliet T., Stumpe K. D., Palestro C. J. Expanding role of 18F-fluoro-D-deoxyglucose PET and PET/CT in spinal infections. Eur Spine J: 2010; 19 4 540 551
24. Leone A., Dell'Atti C., Magarelli N., et al. Imaging of spondylodiscitis. Eur Rev Med Pharmacol Sci: 2012; 16 02 8 19
25. Palestro C. J., Kim C. K., Swyer A. J., Vallabhajosula S., Goldsmith S. J. Radionuclide diagnosis of vertebral osteomyelitis: indium-111-leukocyte and technetium-99m-methylene diphosphonate bone scintigraphy. J Nucl Med: 1991; 32 10 1861 1865
26. Guhlmann A., Brecht-Krauss D., Suger G., et al. Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings. Radiology: 1998; 206 3 749 754 (Pubitemid 28128525)
27. Gratz S., Dörner J., Fischer U., et al. 18F-FDG hybrid PET in patients with suspected spondylitis. Eur J Nucl Med Mol Imaging: 2002; 29 4 516 524
28. Stumpe K. D., Zanetti M., Weishaupt D., Hodler J., Boos N., Von Schulthess G. K. FDG positron emission tomography for differentiation of degenerative and infectious endplate abnormalities in the lumbar spine detected on MR imaging. AJR Am J Roentgenol: 2002; 179 5 1151 1157 (Pubitemid 35204365)
29. De Winter F., Gemmel F., Van De Wiele C., Poffijn B., Uyttendaele D., Dierckx R. 18-Fluorine fluorodeoxyglucose positron emission tomography for the diagnosis of infection in the postoperative spine. Spine: 2003; 28 12 1314 1319 (Pubitemid 36734623)
30. Rosen R. S., Fayad L., Wahl R. L. Increased 18F-FDG uptake in degenerative disease of the spine: characterization with 18F-FDG PET/CT. J Nucl Med: 2006; 47 8 1274 1280 (Pubitemid 47544879)
31. Palestro C. J. 18F-FDG and diabetic foot infections: the verdict is.. J Nucl Med: 2011; 52 7 1009 1011
32. Basu S., Chryssikos T., Houseni M., et al. Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection? Nucl Med Commun: 2007; 28 6 465 472 (Pubitemid 46684196)
33. Palestro C. J., Love C. Nuclear medicine and diabetic foot infections. Semin Nucl Med: 2009; 39 1 52 65
34. Rogers L. C., Bevilacqua N. J. Imaging of the Charcot foot. Clin Podiatr Med Surg: 2008; 25 2 263 274, vii (Pubitemid 351381332)
35. 18F-FDG-PET/CT. J Nucl Med: 2005; 46 3 444 449 (Pubitemid 43093153)
36. Schwegler B., Stumpe K. D., Weishaupt D., et al. Unsuspected osteomyelitis is frequent in persistent diabetic foot ulcer and better diagnosed by MRI than by 18F-FDG PET or 99mTc-MOAB. J Intern Med: 2008; 263 1 99 106 (Pubitemid 350243549)
37. Nawaz A., Torigian D. A., Siegelman E. S., Basu S., Chryssikos T., Alavi A. Diagnostic performance of FDG-PET, MRI, and plain film radiography (PFR) for the diagnosis of osteomyelitis in the diabetic foot. Mol Imaging Biol: 2010; 12 3 335 342
38. Familiari D., Glaudemans A. WJM, Vitale V., et al. Can sequential 18F-FDG PET/CT replace WBC imaging in the diabetic foot? J Nucl Med: 2011; 52 7 1012 1019
39. Kagna O., Srour S., Melamed E., Militianu D., Keidar Z. FDG PET/CT imaging in the diagnosis of osteomyelitis in the diabetic foot. Eur J Nucl Med Mol Imaging: 2012; 39 10 1545 1550
40. Rabkin Z., Israel O., Keidar Z. Do hyperglycemia and diabetes affect the incidence of false-negative 18F-FDG PET/CT studies in patients evaluated for infection or inflammation and cancer? A comparative analysis. J Nucl Med: 2010; 51 7 1015 1020
41. Love C., Marwin S. E., Palestro C. J. Nuclear medicine and the infected joint replacement. Semin Nucl Med: 2009; 39 1 66 78
42. Squire M. W., Della Valle C. J., Parvizi J. Preoperative diagnosis of periprosthetic joint infection: role of aspiration. AJR Am J Roentgenol: 2011; 196 4 875 879
43. Boas F. E., Fleischmann D. Evaluation of two iterative techniques for reducing metal artifacts in computed tomography. Radiology: 2011; 259 3 894 902
44. Lu W., Pauly K. B., Gold G. E., Pauly J. M., Hargreaves B. A. SEMAC: Slice Encoding for Metal Artifact Correction in MRI. Magn Reson Med: 2009; 62 1 66 76
45. Zhuang H., Duarte P. S., Pourdehnad M., et al. The promising role of 18F-FDG PET in detecting infected lower limb prosthesis implants. J Nucl Med: 2001; 42 1 44 48 (Pubitemid 32104776)
46. Chacko T. K., Zhuang H., Stevenson K., Moussavian B., Alavi A. The importance of the location of fluorodeoxyglucose uptake in periprosthetic infection in painful hip prostheses. Nucl Med Commun: 2002; 23 9 851 855
47. Reinartz P., Mumme T., Hermanns B., et al. Radionuclide imaging of the painful hip arthroplasty: positron-emission tomography versus triple-phase bone scanning. J Bone Joint Surg Br: 2005; 87 4 465 470
48. Manthey N., Reinhard P., Moog F., Knesewitsch P., Hahn K., Tatsch K. The use of [18 F]fluorodeoxyglucose positron emission tomography to differentiate between synovitis, loosening and infection of hip and knee prostheses. Nucl Med Commun: 2002; 23 7 645 653 (Pubitemid 34748004)
49. Van Acker F., Nuyts J., Maes A., et al. FDG-PET, 99mtc-HMPAO white blood cell SPET and bone scintigraphy in the evaluation of painful total knee arthroplasties. Eur J Nucl Med: 2001; 28 10 1496 1504
50. Stumpe K. D., Nötzli H. P., Zanetti M., et al. FDG PET for differentiation of infection and aseptic loosening in total hip replacements: comparison with conventional radiography and three-phase bone scintigraphy. Radiology: 2004; 231 2 333 341 (Pubitemid 38552886)
51. Love C., Marwin S. E., Tomas M. B., et al. Diagnosing infection in the failed joint replacement: a comparison of coincidence detection 18F-FDG and 111In-labeled leukocyte/99mTc-sulfur colloid marrow imaging. J Nucl Med: 2004; 45 11 1864 1871 (Pubitemid 47618444)
52. Pill S. G., Parvizi J., Tang P. H., et al. Comparison of fluorodeoxyglucose positron emission tomography and (111)indium-white blood cell imaging in the diagnosis of periprosthetic infection of the hip. J Arthroplasty: 2006; 21 6 02 91 97 (Pubitemid 44293270)
53. Kwee T. C., Kwee R. M., Alavi A. FDG-PET for diagnosing prosthetic joint infection: systematic review and metaanalysis. Eur J Nucl Med Mol Imaging: 2008; 35 11 2122 2132
54. Forstrom L. A., Dunn W. L., Mullan B. P., Hung J. C., Lowe V. J., Thorson L. M. Biodistribution and dosimetry of [(18)F]fluorodeoxyglucose labelled leukocytes in normal human subjects. Nucl Med Commun: 2002; 23 8 721 725 (Pubitemid 34837001)
55. Dumarey N., Egrise D., Blocklet D., et al. Imaging infection with 18F-FDG-labeled leukocyte PET/CT: initial experience in 21 patients. J Nucl Med: 2006; 47 4 625 632 (Pubitemid 46768463)
56. Rini J. N., Bhargava K. K., Tronco G. G., et al. PET with FDG-labeled leukocytes versus scintigraphy with 111In-oxine-labeled leukocytes for detection of infection. Radiology: 2006; 238 3 978 987 (Pubitemid 43289930)
57. Rini J. N., Palestro C. J. Imaging of infection and inflammation with 18F-FDG-labeled leukocytes. Q J Nucl Med Mol Imaging: 2006; 50 2 143 146 (Pubitemid 44044026)
58. Diaz L. A. Jr, Foss C. A., Thornton K., et al. Imaging of musculoskeletal bacterial infections by [124I]FIAU-PET/CT. PLoS ONE: 2007; 2 10 e1007
59. Nanni C., Errani C., Boriani L., et al. 68Ga-citrate PET/CT for evaluating patients with infections of the bone: preliminary results. J Nucl Med: 2010; 51 12 1932 1936
60. Petrik M., Haas H., Dobrozemsky G., et al. 68Ga-siderophores for PET imaging of invasive pulmonary aspergillosis: proof of principle. J Nucl Med: 2010; 51 4 639 645
61. Ujula T., Salomäki S., Virsu P., et al. Synthesis, 68Ga labeling and preliminary evaluation of DOTA peptide binding vascular adhesion protein-1: a potential PET imaging agent for diagnosing osteomyelitis. Nucl Med Biol: 2009; 36 6 631 641
62. Langer O., Brunner M., Zeitlinger M., et al. In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PET. Eur J Nucl Med Mol Imaging: 2005; 32 2 143 150 (Pubitemid 40248483)
63. Lindsay M. J., Siegel B. A., Tunis S. R., et al. The National Oncologic PET Registry: expanded Medicare coverage for PET under coverage with evidence development. AJR Am J Roentgenol: 2007; 188 4 1109 1113 (Pubitemid 46496951)
64. Hillner B. E., Siegel B. A., Liu D., et al. Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry. J Clin Oncol: 2008; 26 13 2155 2161